Pre-Targeting with in Vivo Click Chemistry for Next-Gen ADCs & Radiopharmaceutical Therapies (RTPs)
Time: 3:40 pm
day: Day One P3
Details:
- Mechanisms of dose-limiting, off-target toxicities associated with ADCs
- Pre-targeting as a solution to overcome off-target toxicities and deliver more payload to the tumor – or all payloads classes
- Using in vivo click chemistry as a reunion technology and how this can be used to improve efficacy by minimizing exposure to the body and maximizing tumor drug considerations